Viewing Study NCT07023861


Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2025-12-27 @ 10:19 PM
Study NCT ID: NCT07023861
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-06-17
First Post: 2025-05-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Sponsor: Affiliated Hospital of Jiangnan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module